Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen
- 31 October 1985
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 18 (5) , 592-600
- https://doi.org/10.1002/ana.410180513
Abstract
Sera from 6 of 12 patients with paraneoplastic cerebellar degeneration (PCD) contained anti–Purkinje cell antibodies, as determined by indirect immunofluorescence on frozen sections of normal human cerebellum. Samples of cerebrospinal fluid from 2 of the patients with serum antibodies were tested, and both specimens contained anti–Purkinje cell antibody. The anti-Purkinje cell antibodies were polyclonal, fixed complement, and were present in all patients at serum dilutions of 1:1,000 or greater. Antibody activity could not be suppressed by preabsorption of sera with human or animal brain and tissue powders or with fresh crude human cerebellar extracts. No anti–Purkinje cell antibodies were detected in control sera from 167 neurologically normal cancer patients, 32 normal volunteers, 10 patients with other causes of cerebellar degeneration, or 8 patients with other paraneoplastic neurological diseases. Preliminary evidence suggests that the Purkinje antigen is a protein that is often concentrated in the periphery of the cytoplasm in disc-shaped structures. Patients with antibodies often developed signs of PCD near the time of detection of the tumor and had relentless progression of neurological disease. Patients without antibodies frequently had cancer for months to years before PCD developed, and often had spontaneous stabilization of neurological disease with time. Four patients without and 3 patients with antibodies underwent plasmapheresis without response.This publication has 11 references indexed in Scilit:
- Rating parkinsonian disabilityNeurology, 1984
- Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinomaAnnals of Neurology, 1983
- Cerebellar cortical degeneration with ovarian carcinomaPostgraduate Medical Journal, 1982
- The use of avidin-biotin interaction in immunoenzymatic techniques.Journal of Histochemistry & Cytochemistry, 1979
- Cerebellar Degeneration With Hodgkin DiseaseArchives of Neurology, 1976
- Carcinomatous neuromyopathy: 2. Immunological studies: An electrophysiological and immunological study of patients with carcinoma of the lungJournal of Neurology, Neurosurgery & Psychiatry, 1974
- LYMPHOCYTE SENSITISATION: AN IN-VITRO TEST FOR CANCER ?The Lancet, 1970
- Cerebellar degeneration with Hodgkin's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1966
- Méthode permettant l'étude conjuguée des propriétés électrophorétiques et immunochimiques d'un mélange de protéines. Application au sérum sanguinBiochimica et Biophysica Acta, 1953
- SUBACUTE CORTICAL CEREBELLAR DEGENERATION AND ITS RELATION TO CARCINOMAJournal of Neurology, Neurosurgery & Psychiatry, 1951